Depression is an early disease manifestation in lupus-prone MRL/lpr mice

被引:67
|
作者
Gao, Hua-Xin [2 ]
Campbell, Sean R. [2 ]
Cui, Min-Hui [3 ]
Zong, Pu [3 ]
Hee-Hwang, Jong [3 ]
Gulinello, Maria [4 ]
Putterman, Chaim [1 ,2 ]
机构
[1] Albert Einstein Coll Med, Div Rheumatol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Magnet Resonance Res Ctr, Bronx, NY 10461 USA
[4] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA
关键词
Systemic Lupus Erythematosus; Neuropsychiatric lupus; Anti-DNA antibodies; Depression; MRL-LPR MICE; MAGNETIC-RESONANCE-SPECTROSCOPY; RIBOSOMAL-P ANTIBODIES; AUTOREACTIVE B-CELLS; ELEVATED-PLUS-MAZE; PSYCHIATRIC MANIFESTATIONS; NEUROPSYCHIATRIC MANIFESTATIONS; ANTIPHOSPHOLIPID SYNDROME; PROTEIN AUTOANTIBODIES; COGNITIVE IMPAIRMENT;
D O I
10.1016/j.jneuroim.2008.11.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many lupus patients develop neuropsychiatric manifestations, including cognitive dysfunction, depression, and anxiety. However, it is not clear if neuropsychiatric lupus is a primary disease manifestation, or is secondary to non-CNS disease. We found that MRL/lpr lupus-prone mice exhibited significant depression-like behavior already at 8 weeks of age, despite normal visual working memory, locomotor coordination and social preference. Moreover, depression was significantly correlated with titers of autoantibodies against DNA, NMDA receptors and cardiolipin. Our results indicate that lupus mice develop depression and CNS dysfunction very early in the course of disease, in the absence of substantial pathology involving other target organs. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:45 / 56
页数:12
相关论文
共 50 条
  • [31] Cyclic GMP catabolism up-regulation in MRL/lpr lupus-prone mice is associated with organ remodeling
    Yougbare, Issaka
    Keravis, Therese
    Abusnina, Abdurazzag
    Decossas, Marion
    Schall, Nicolas
    Muller, Sylviane
    Lugnier, Claire
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (07): : 916 - 926
  • [32] Effects of Anti-High Mobility Group Box 1 Antibody for MRL/Lpr lupus-Prone Mice
    Watanabe, Haruki
    Watanabe, Katsue S.
    Liu, Keyue
    Yan, Minglu
    Hiramatsu, Sumie
    Zeggar, Sonia
    Ohashi, Keiji
    Katsuyama, Eri
    Miyawaki, Yoshia
    Morishiata, Michiko
    Katsuyama, Takayuki
    Narazaki, Mariko
    Tatebe, Noriko
    Kawabata, Tomoko
    Sada, Ken-ei
    Nishibori, Masahiro
    Wada, Jun
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [33] Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice - Additive and hierarchical properties of polygenic inheritance
    Nishihara, M
    Terada, M
    Kamogawa, J
    Ohashi, Y
    Mori, S
    Nakatsuru, S
    Nakamura, Y
    Nose, M
    ARTHRITIS AND RHEUMATISM, 1999, 42 (12): : 2616 - 2623
  • [34] The Therapeutic Effects of the Chinese Herbal Medicine, Lang Chuang Fang Granule, on Lupus-Prone MRL/lpr Mice
    Huang, Kai-Peng
    Zhang, Zhi-Hao
    Li, Rui-Ming
    Chen, Xiao
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [35] alpha beta T cell-dependent and -independent contributions to autoimmunity in lupus-prone MRL/Mp-lpr/lpr mice
    Peng, S
    Madaio, M
    Hughes, D
    Crispe, N
    Owen, M
    Hayday, A
    Craft, J
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A222 - A222
  • [36] Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice
    Knight, Jason S.
    Subramanian, Venkataraman
    O'Dell, Alexander A.
    Yalavarthi, Srilakshmi
    Zhao, Wenpu
    Smith, Carolyne K.
    Hodgin, Jeffrey B.
    Thompson, Paul R.
    Kaplan, Mariana J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (12) : 2199 - 2206
  • [37] TWEAKing Cutaneous Manifestations In MRL-Lpr/Lpr Lupus Prone mice.
    Xia, Yumin
    Blecher, Karin
    Wen, Jing
    Michaelson, Jennifer S.
    Burkly, Linda C.
    Friedman, Adam
    Putterman, Chaim
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S713 - S713
  • [38] Fn14 Deficiency Ameliorates Neuropsychiatric Disease In MRL-Lpr/Lpr Lupus Prone Mice
    Wen, Jing
    Xia, Yumin
    Michaelson, Jennifer S.
    Burkly, Linda C.
    Gulinello, Maria
    Putterman, Chaim
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S219 - S219
  • [39] Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist
    Itto, Rina
    Oe, Yuji
    Imaruoka, Kenta
    Sato, Emiko
    Sekimoto, Akiyo
    Yamakage, Shu
    Kumakura, Satoshi
    Sato, Hiroshi
    Ito, Sadayoshi
    Takahashi, Nobuyuki
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 249 (02): : 127 - 133
  • [40] Therapeutic effects of soluble human leukocyte antigen G2 isoform in lupus-prone MRL/lpr mice
    Watanabe, Hiroshi
    Kuroki, Kimiko
    Yamada, Chisato
    Saburi, Yukari
    Maeda, Naoyoshi
    Maenaka, Katsumi
    HUMAN IMMUNOLOGY, 2020, 81 (04) : 186 - 190